New York City-based Icahn School of Medicine at Mount Sinai hired Adam Margolin, PhD, to serve as professor and chair of the genetics and genomic sciences department of genetics and senior associate dean of precision medicine. He will also lead the Icahn Institute for Data Science and Genomic Technology.
Dr. Margolin was previously director of computational biology and professor of biomedical engineering at Portland-based Oregon Health & Science University. He earned his PhD in biomedical informatics from New York City-based Columbia University. He has experience developing machine-learning algorithms and software systems to enable collaborative analysis.
The $200 million, newly relaunched Icahn Institute for Data Science and Genomic Technology will focus on leveraging large molecular datasets to predict new therapies for complex diseases and tailoring therapies to individual patients.
Mount Sinai plans to recruit 30 new data science- and genomic technology-focused faculty members as well as 25 data scientists over the next decade for projects that aim to interpret large-scale biomolecular data and discover new precision therapies.
"We are creating a program built for the way science will be done in the future. The traditional academic model, organized around siloed individual labs, cannot achieve the speed, agility and integration we need to advance biomedical research of today," said Dr. Margolin. "Our program will be built from the outset to enable world class data scientists, technology innovators and disease experts to advance large-scale team-oriented goals that could not be achieved in a more traditional model."